You have access
Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations
John D. Ayres
PDA Journal of Pharmaceutical Science and Technology November 2018, 72 (6) 626-639; DOI: https://doi.org/10.5731/pdajpst.2018.008615